Reut-Maccabim, Israel

Keren Jakobi

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Keren Jakobi: Innovator in Lupus Diagnosis

Introduction

Keren Jakobi is a notable inventor based in Reut-Maccabim, Israel. He has made significant contributions to the field of medical diagnostics, particularly in the diagnosis of systemic lupus erythematosus (SLE). With a total of two patents to his name, Jakobi's work is recognized for its innovative approach to disease detection.

Latest Patents

Keren Jakobi's latest patents focus on methods and kits for diagnosing or monitoring systemic lupus erythematosus. His inventions utilize protein, peptide, and oligonucleotide antigens to create a specific antibody reactivity profile. This profile is particularly useful in diagnosing or monitoring SLE in a subject, providing a valuable tool for healthcare professionals.

Career Highlights

Throughout his career, Keren Jakobi has worked with prominent companies in the research and development sector. Notably, he has been associated with Yeda Research and Development Co. Ltd. and Immunarray Ltd. His work in these organizations has contributed to advancements in medical diagnostics and therapeutic solutions.

Collaborations

Keren Jakobi has collaborated with several professionals in his field, including Rachel Sorek and Pennina Safer. These collaborations have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Keren Jakobi's contributions to the diagnosis of systemic lupus erythematosus highlight his role as an innovator in the medical field. His patents and collaborations reflect a commitment to improving diagnostic methods and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…